# JoLT-Ca Sublobar Resection (SR) Versus Stereotactic Ablative Radiotherapy (SAbR) for Lung Cancer

> **NCT02468024** · PHASE3 · RECRUITING · sponsor: **University of Texas Southwestern Medical Center** · enrollment: 272 (estimated)

## Conditions studied

- Non-Small Cell Lung Cancer

## Interventions

- **PROCEDURE:** Lung Surgery
- **RADIATION:** Radiation therapy

## Key facts

- **NCT ID:** NCT02468024
- **Lead sponsor:** University of Texas Southwestern Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2015-07
- **Primary completion:** 2028-12
- **Final completion:** 2028-12
- **Target enrollment:** 272 (ESTIMATED)
- **Last updated:** 2026-04-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02468024

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02468024, "JoLT-Ca Sublobar Resection (SR) Versus Stereotactic Ablative Radiotherapy (SAbR) for Lung Cancer". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02468024. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*